Article Per Year (5 Year)
p-Index From 2021 - 2026
0.882
P-Index
This Author published in this journals
All Journal Prosiding Seminar Nasional COSMIC Kedokteran Medicosphere
Agustina, Putri Noviana
Unknown Affiliation
Immunology & microbiology Industrial & Manufacturing Engineering Mechanical Engineering Medicine & Pharmacology Nursing Physics Public Health Social Sciences

Published : 5 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Medicosphere

 1 
The Impact of Pneumococcal Conjugate Vaccines on Pneumonia in Children: A Review of Recent Studies Agustina, Putri Noviana; Agastya, Wayan Dhea
Journal of Diverse Medical Research: Medicosphere Vol. 1 No. 3 (2024): J Divers Med Res 2024
Publisher : Faculty of Medical - UPN Veteran Jawa Timur

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33005/jdiversemedres.v1i3.131

Abstract

Background. The introduction of pneumococcal conjugate vaccines (PCVs) has significantly reduced the burden of pneumonia in children worldwide, leading to decreased hospitalization rates, lower severity of disease, and a reduction in antibiotic resistance. However, regional disparities persist, particularly in low- and middle-income countries where healthcare infrastructure and access to vaccines are often limited. Methods. This review synthesizes findings from recent studies on the impact of PCVs on the incidence, severity, and management of pneumonia in children. It includes analyses of studies conducted in various regions, highlighting the global and regional effects of PCVs on pneumonia hospitalization rates, vaccine effectiveness against severe disease, and antibiotic resistance. Discussion. The review underscores the importance of PCVs in reducing pneumonia-related hospitalization rates, disease severity, and antibiotic resistance globally. Nevertheless, challenges persist in addressing regional disparities, particularly in underserved areas with limited healthcare infrastructure and vaccine accessibility. Conclusion. Continued surveillance and research are essential to evaluate the long-term effectiveness of newer PCV formulations. Developing strategies to improve vaccination coverage in underserved populations and monitoring the emergence of new serotypes are critical for adapting public health strategies. By addressing these challenges, the protective benefits of PCVs can be sustained, ultimately improving health outcomes for children Keywords:Pneumococcal conjugate vaccine, pneumonia, children, hospitalization, vaccine effectiveness, antibiotic resistance
Co-Authors Agastya, Wayan Dhea Arbani, Rafi Auliya Auliya, Rafi Fahma, Hilmia Fara Disa Durry Rusdi, Muhammad Salsabeela Satyafebrianti, Kendra Callista Tedjaprasadja, Leonardo Zahira, Alya Shofiyah